{
  "title": "Travel Rebound Hindered by Delta Variant",
  "itunes:title": "Travel Rebound Hindered by Delta Variant",
  "description": "<p>Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the use of the drug ivermectin to treat Covid-19. Bloomberg Businessweek Editor Joel Weber shares stories from the new issue of Businessweek Magazine<em>. </em>Axel Hefer, CEO at Trivago, talks about the company's earnings and how new global virus cases are impacting the travel industry. And we Drive to the Close with Jay Hatfield, CEO at Infrastructure Capital Advisors.</p><p>Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the use of the drug ivermectin to treat Covid-19. Bloomberg Businessweek Editor Joel Weber shares stories from the new issue of Businessweek Magazine<em>. </em>Axel Hefer, CEO at Trivago, talks about the company's earnings and how new global virus cases are impacting the travel industry. And we Drive to the Close with Jay Hatfield, CEO at Infrastructure Capital Advisors.</p><p>Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "4dadd96c-f171-11eb-b597-bf74cf65f490",
  "omny:clipId": "3a4f1d7e-f4aa-4d20-a94d-ae2b002baf72",
  "pubDate": "Fri, 30 Jul 2021 20:15:33 +0000",
  "itunes:duration": 2526,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-businessweek/travel-rebound-hindered-by-delta-variant"
}